Sort
21,453 grants matching “tuberculosis”
Vitamin D Inhibition of HIV and M. Tuberculosis Coinfection in Macrophages
$191,194Stephen A Spector · University Of California, San Diego · R21 · FY2010 · AI
Identification of Mycobacterium tuberculosis genes that mediate inhibition of the host cell IFN-beta signaling
$191,171Volker Briken · Univ Of Maryland, College Park · R21 · FY2021 · AI
CD1 IMMUNE RESPONSES AND VACCINES IN ANIMAL MODELS OF TB
$191,170Brigham And Women'S Hospital · R01 · FY2002 · AI
Animal Models Core
$191,154Myron E Hinsdale · Oklahoma State University Stillwater · P30 · FY2024 · GM
Mobilization of tissue-resident lymphocytes during secondary infection
$191,128Tessa Bergsbaken · Rbhs-New Jersey Medical School · R21 · FY2021 · AI
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$191,122N Alexand Bowler · Wyoming State Department Of Health · U52 · FY2008 · PS
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$191,122N Alexand Bowler · Wyoming State Department Of Health · U52 · FY2009 · PS
High resolution plasma metabolomics to identify biomarkers of tuberculosis
$191,084Jeffrey M Collins · Emory University · K23 · FY2019 · AI
High resolution plasma metabolomics to identify biomarkers of tuberculosis
$191,084Jeffrey M Collins · Emory University · K23 · FY2020 · AI
Using systems science to optimize the impact of point-of-care viral load testing for pediatric HIV management
$191,066Rena Chiman Patel · University Of Washington · R21 · FY2021 · MH
Sequencing and Epigenetics Core
$190,992Gregory Seumois · La Jolla Institute For Immunology · U19 · FY2020 · AI
Surface dependent inhibition of Mycobacterium abscessus by Pseudomonas aeruginosa
$190,969Daniel J Wozniak · Ohio State University · R21 · FY2025 · AI
Role of IFNs and IFNGR in susceptibility to bacteria in Down syndrome
$190,965Laurel L Lenz · University Of Colorado Denver · R21 · FY2022 · AI
Construction of safe and effective live tuberculosis vaccines
$190,879Steven A Porcelli · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · AI
A Double-blind, Randomized Trial of Moxifloxacin and Placebo for Six Months vs
$190,864Mauro Schechter · Johns Hopkins University · U19 · FY2009 · AI
Developing a Transcriptomic Assay for Rapid Antimicrobial Susceptibility Testing of Mycobacterium abscessus in Clinical Microbiology Laboratories
$190,768Husain Poonawala · Tufts Medical Center · K08 · FY2025 · AI
PHARMACOKINETICS OF THE ANTITUBERCULOSIS DRUGS
$190,747University Of Colorado Denver · M01 · FY2002 · RR
TREATMENT OF REFRACTORY NON-TUBERCULOSIS MYCOBACTERIAL INFECTIONS W/ INTERFERON
$190,747University Of Colorado Denver · M01 · FY2002 · RR
TREATMENT OF REFRACTORY NON-TUBERCULOSIS MYCOBACTERIAL INFECTIONS W/ INTERFERON
$190,747University Of Colorado Denver · M01 · FY2001 · RR
PHARMACOKINETICS OF THE ANTITUBERCULOSIS DRUGS
$190,747University Of Colorado Denver · M01 · FY2001 · RR
Core--Animal and Infection
$190,742John Chan · Albert Einstein College Of Medicine · P01 · FY2009 · AI
Immune responses in autoimmune liver diseases
$190,697Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
MODIFYING THE LUNG TO INDUCE STERILE VACCINE-INDUCED PROTECTION AGAINST MTB INFECTION
$190,625Shabaana A. Khader · Washington University · R21 · FY2016 · AI
Immunology Training Program-Predoctoral
$190,625Brian A Cobb · Case Western Reserve University · T32 · FY2018 · AI
THE ROLE OF UBIQUILINS IN INNATE IMMUNITY TO TUBERCULOSIS
$190,625Jennifer A Philips · Washington University · R21 · FY2015 · AI